Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Amortizatization of Intangibles (2023 - 2025)

Contineum Therapeutics (CTNM) has 3 years of Amortizatization of Intangibles data on record, last reported at $98000.0 in Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles rose 104.89% year-over-year to $98000.0; the TTM value through Dec 2025 reached $791000.0, down 9.29%, while the annual FY2025 figure was $791000.0, 9.29% down from the prior year.
  • Amortizatization of Intangibles reached $98000.0 in Q4 2025 per CTNM's latest filing, up from $1000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.8 million in Q2 2024 and bottomed at -$2.0 million in Q4 2024.
  • Average Amortizatization of Intangibles over 3 years is $219000.0, with a median of $243000.0 recorded in 2023.
  • The widest YoY moves for Amortizatization of Intangibles: up 663.64% in 2024, down 291.21% in 2024.
  • A 3-year view of Amortizatization of Intangibles shows it stood at -$512000.0 in 2023, then tumbled by 291.21% to -$2.0 million in 2024, then skyrocketed by 104.89% to $98000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were $98000.0 in Q4 2025, $1000.0 in Q3 2025, and $407000.0 in Q2 2025.